Catalent Inc.

CTLT NYS
Pharmaceuticals
Somerset, NJ
2016 Revenue (US$ Millions)$1,848
Revenue Growth (%)0.94%
2015 Revenue (US$ Millions)$1,831
Net Income (US$ Millions)$112
Common Shares Outstanding (Millions)124.71
Earnings Per Share (US$)$0.89
Price to Earnings Ratio38.44
Total Equity (US$ Millions)$636
Return on Equity (%)17.59%
Long Term Debt (US$ Millions)$1,833
Debt to Equity Ratio (%)2.88%
Market Capitalization (US$ Millions)$2,867
Total Assets (US$ Millions)$3,091
Current Assets (US$ Millions)$790
Inventories (US$ Millions)$155
Current Liabilities (US$ Millions)$391
Cost Of Goods Sold (US$ Millions)$1,261
Asset Turnover0.59
Inventory Turnover8.76